Inspire Medical Systems, Inc. INSP
59.41 USD +0.29 (+0.49%)
Regular-session close
59.41 0.00 0.00%
After hours · Nov 17, 4:00 PM ET
57.84 Day range 59.48
38.91 52-week range 147.03
- YTD
- -35.58%
- 1 year
- -30.00%
News
globenewswire.com Inspire Medical Systems, Inc. to Present at the Piper Sandler 38th Annual Healthcare Conference MINNEAPOLIS, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative,…benzinga.com Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Lowers Price Target to $93 Freedom Capital Markets analyst Keith Hinton maintains Inspire Medical Systems (NYSE:INSP) with a Buy and lowers the price target from $97 to $93.
zacks.com Here's Why You Should Retain INSP Stock in Your Portfolio for Now Inspire Medical's strong Inspire V adoption, improving reimbursement clarity and patient access initiatives support growth despite near-term headwinds.
zacks.com INSP Is Up 12.1% in Three Months: Can Its Rally Continue From Here? Inspire Medical shares have rallied 12.1% in three months, but reimbursement hurdles and weak revenues raise questions about whether the gains can continue.benzinga.com JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $65 JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $60 to $65.
benzinga.com Truist Securities Reiterates Hold on Inspire Medical Systems, Lowers Price Target to $76 Truist Securities analyst Richard Newitter reiterates Inspire Medical Systems (NYSE:INSP) with a Hold and lowers the price target from $78 to $76.
benzinga.com Wells Fargo Maintains Equal-Weight on Inspire Medical Systems, Raises Price Target to $69 Wells Fargo analyst Larry Biegelsen maintains Inspire Medical Systems (NYSE:INSP) with a Equal-Weight and raises the price target from $56 to $69.
benzinga.com Evercore ISI Group Maintains In-Line on Inspire Medical Systems, Lowers Price Target to $60 Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a In-Line and lowers the price target from $72 to $60.
benzinga.com Barclays Maintains Underweight on Inspire Medical Systems, Lowers Price Target to $62 Barclays analyst Christopher Pasquale maintains Inspire Medical Systems (NYSE:INSP) with a Underweight and lowers the price target from $65 to $62.
benzinga.com These Analysts Increase Their Forecasts On Inspire Medical After Strong Q3 Results Inspire Medical beat Q3 earnings and sales estimates, narrowed FY2026 guidance, while analysts raised price targets to $77 and $70.benzinga.com Piper Sandler Maintains Neutral on Inspire Medical Systems, Raises Price Target to $70 Piper Sandler analyst Adam Maeder maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $60 to $70.
benzinga.com Baird Maintains Neutral on Inspire Medical Systems, Raises Price Target to $77 Baird analyst Mike Polark maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $73 to $77.
benzinga.com Inspire Medical Systems Q3 2026 Earnings Call Transcript Inspire Medical Systems (NYSE:INSP) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…benzinga.com Inspire Medical Systems Q3 Adj. EPS $0.14 Beats $0.09 Estimate, Sales $206.695M Beat $204.304M Estimate Inspire Medical Systems (NYSE:INSP) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.09 by 55.56 percent. This is a 63.16 percent decrease over earnings…
benzinga.com Inspire Medical Systems Narrows FY2026 Adj EPS Guidance from $1.05-$1.45 to $1.20-$1.40 vs $1.25 Est; Narrows FY2026 Sales Guidance from $835.000M-$875.000M to $850.000M-$860.000M vs $853.615M Est Inspire Medical Systems (NYSE:INSP) narrows FY2026 Adj EPS guidance from $1.05-$1.45 to $1.20-$1.40 vs $1.25 analyst estimate. Narrows FY2026 sales outlook from $835.000 million-$875.000 million to…
